irinotecan has been researched along with Carcinoma, Medullary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, T; Hakoshima, M; Hattori, Y; Koga, K; Komori, M; Maitani, Y; Narishima, R; Yamasaki, M | 1 |
| Ball, DW; Denmeade, SR; Nelkin, BD; Park, JI; Rosen, DM; Ruggeri, B; Strock, CJ | 1 |
2 other study(ies) available for irinotecan and Carcinoma, Medullary
| Article | Year |
|---|---|
Combination of RET siRNA and irinotecan inhibited the growth of medullary thyroid carcinoma TT cells and xenografts via apoptosis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carcinoma, Medullary; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Humans; Irinotecan; Mice; Mice, Inbred ICR; Mice, Nude; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; RNA, Small Interfering; Thyroid Neoplasms; Xenograft Model Antitumor Assays | 2010 |
Activity of irinotecan and the tyrosine kinase inhibitor CEP-751 in medullary thyroid cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Camptothecin; Carbazoles; Carcinoma, Medullary; cdc25 Phosphatases; Cell Cycle; Cell Division; Cell Line, Tumor; Checkpoint Kinase 1; Enzyme Inhibitors; Histones; Humans; Irinotecan; Mice; Mice, Nude; Neoplasm Transplantation; Protein Kinases; Protein-Tyrosine Kinases; S Phase; Signal Transduction; Thyroid Neoplasms; Transplantation, Heterologous | 2006 |